South African pharmaceutical company Aspen Pharmacare said on Monday it had entered into a preliminary agreement with Johnson & Johnson to commercially manufacture its COVID-19 vaccine candidate.
South Africa’s Aspen agrees with J&J to manufacture COVID-19 vaccine candidate
